Deutsche Bank’s Protara Therapeutics TARA Stock Holding History
Bought
Maintained
Sold
Other funds holding TARA
JT
VCIM
O
SCM
ACA
IHAM
Deutsche Bank's TARA Position: Q2 2026 in Review
Deutsche Bank increased its Protara Therapeutics (TARA) stake by 6.9% in Q2 2026, buying an estimated $17.8K and bringing the position to 57,713 shares worth $220K. The position accounts for ﹤0.01% of the portfolio, ranked #3200.
Deutsche Bank first reported a position in TARA in Q4 2014 and has held it in 16 quarters since. The position peaked at $281K in Q1 2026. 120 funds tracked by Wall St. Rank hold TARA as of Q2 2026.
- Deutsche Bank held 57,713 shares of Protara Therapeutics worth $220K as of Q2 2026.
- Deutsche Bank bought 3,738 Protara Therapeutics shares in Q2 2026, an estimated $17.8K.
- Protara Therapeutics made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #3200 holding.
- Deutsche Bank first reported a position in Protara Therapeutics in Q4 2014 and has held it in 16 quarters since.
- Deutsche Bank's Protara Therapeutics position peaked at $281K in Q1 2026.
- 120 funds tracked by Wall St. Rank held Protara Therapeutics as of Q2 2026.
Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.